# FDA recall D-0570-2023

> **The Harvard Drug Group** · Class III · drug recall initiated 2023-04-24.

## Product

Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61

## Reason for recall

Product mixup: one foreign tablet found in product.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0570-2023
- **Recalling firm:** The Harvard Drug Group
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-04-24
- **Report date:** 2023-05-17
- **Termination date:** 2024-04-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** La Vergne, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0570-2023

## Citation

> AI Analytics. FDA recall D-0570-2023. Retrieved 2026-07-17 from https://api.ai-analytics.org/recall/D-0570-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*